Monopar Therapeutics Inc Share Price Today: Live Updates & Key Insights
Monopar Therapeutics Inc share price today is $55.67, up -5.9%. The stock opened at $58.02 against the previous close of $58.67, with an intraday high of $58.26 and low of $55.42.
Monopar Therapeutics Inc Share Price Chart
Monopar Therapeutics Inc
Monopar Therapeutics Inc Share Price Performance
Monopar Therapeutics Inc Institutional Holdings
Monopar Therapeutics Inc Market Status
Monopar Therapeutics Inc Fundamentals
Market Cap 368.95 M
PB Ratio 2.7697
PE Ratio 0.0
Enterprise Value 248.46 M
Total Assets 60.29 M
Volume 266041
Monopar Therapeutics Inc Company Financials
About Monopar Therapeutics Inc & investment objective
Company Information Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Organisation Biotechnology
Employees 14
Industry Biotechnology
CEO Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Monopar Therapeutics Inc FAQs
What is the share price of Monopar Therapeutics Inc today?
The current share price of Monopar Therapeutics Inc is $55.67.
Can I buy Monopar Therapeutics Inc shares in India?
Yes, Indian investors can buy Monopar Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Monopar Therapeutics Inc shares in India?
You can easily invest in Monopar Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Monopar Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Monopar Therapeutics Inc.
Can I buy fractional shares of Monopar Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Monopar Therapeutics Inc?
Monopar Therapeutics Inc has a market cap of $368.95 M.
In which sector does Monopar Therapeutics Inc belong?
Monopar Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Monopar Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Monopar Therapeutics Inc?
The PE ratio of Monopar Therapeutics Inc is N/A and the PB ratio is 2.77.